Literature DB >> 25796368

Evidence of epithelial-mesenchymal transition in canine prostate cancer metastasis.

Carlos Eduardo Fonseca-Alves1, Priscila Emiko Kobayashi2, Luis Gabriel Rivera-Calderón2, Renée Laufer-Amorim2.   

Abstract

The epithelial-mesenchymal transition (EMT) is a fundamental event responsible for the invasiveness and metastasis of epithelial tumours. The EMT has been described in many human cancers, but there are few reports of this phenomenon in veterinary oncology. Due to the importance of this process, the current study evaluated mesenchymal and epithelial marker protein expression in prostate lesions from dogs. Our results indicate both a loss of E-cadherin and translocation of β-catenin from the membrane to the cytoplasm and nucleus in the tumour group. Vimentin expression in the tumour group was higher than in normal tissue. All of the metastases were positive for prostate-specific antigen, pan-cytokeratin and E-cadherin, although fewer positive cells were present than in the primary tumours. The immunohistochemical results showed a loss of epithelial markers and a gain of a mesenchymal marker among metastatic cells, suggesting that the EMT occurs during the metastatic process of canine prostate carcinoma.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dog; Epithelial–mesenchymal crosstalk; Immunohistochemistry; Prostate cancer

Mesh:

Substances:

Year:  2015        PMID: 25796368     DOI: 10.1016/j.rvsc.2015.03.001

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  8 in total

Review 1.  Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.

Authors:  Eduardo de Paula Nascente; Renée Laufer Amorim; Carlos Eduardo Fonseca-Alves; Veridiana Maria Brianezi Dignani de Moura
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

2.  Pulmonary carcinoma with metastasis in a long-finned pilot whale (Globicephala melas).

Authors:  Cristian M Suárez-Santana; Carolina Fernández-Maldonado; Josué Díaz-Delgado; Manuel Arbelo; Alejandro Suárez-Bonnet; Antonio Espinosa de Los Monteros; Nakita Câmara; Eva Sierra; Antonio Fernández
Journal:  BMC Vet Res       Date:  2016-10-11       Impact factor: 2.741

3.  Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.

Authors:  Carlos Eduardo Fonseca-Alves; Priscilla Emiko Kobayashi; Chiara Palmieri; Renée Laufer-Amorim
Journal:  BMC Vet Res       Date:  2017-12-06       Impact factor: 2.741

4.  Cross-species oncogenic signatures of breast cancer in canine mammary tumors.

Authors:  Tae-Min Kim; In Seok Yang; Byung-Joon Seung; Sejoon Lee; Dohyun Kim; Yoo-Jin Ha; Mi-Kyoung Seo; Ka-Kyung Kim; Hyun Seok Kim; Jae-Ho Cheong; Jung-Hyang Sur; Hojung Nam; Sangwoo Kim
Journal:  Nat Commun       Date:  2020-07-17       Impact factor: 14.919

5.  Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.

Authors:  Eva-Maria Packeiser; Marion Hewicker-Trautwein; Heike Thiemeyer; Annika Mohr; Johannes Junginger; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

6.  E-Cadherin Downregulation is Mediated by Promoter Methylation in Canine Prostate Cancer.

Authors:  Carlos Eduardo Fonseca-Alves; Priscila Emiko Kobayashi; Antonio Fernando Leis-Filho; Patricia de Faria Lainetti; Valeria Grieco; Hellen Kuasne; Silvia Regina Rogatto; Renee Laufer-Amorim
Journal:  Front Genet       Date:  2019-11-29       Impact factor: 4.599

7.  Clinicopathological and immunohistochemical description of an intrapelvic hepatoid gland carcinoma in a 14-year-old Teckel dog.

Authors:  Joelson Jardim; Priscila E Kobayashi; Patrícia D Cosentino; Ana Alcaraz; Renée Laufer-Amorim; Carlos E Fonseca-Alves
Journal:  Vet Q       Date:  2018-12       Impact factor: 3.320

8.  RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.

Authors:  Hugo Murua Escobar; Ingo Nolte; Eva-Maria Packeiser; Leila Taher; Weibo Kong; Mathias Ernst; Julia Beck; Marion Hewicker-Trautwein; Bertram Brenig; Ekkehard Schütz
Journal:  Cancer Cell Int       Date:  2022-02-02       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.